Atlas Trials

HR Positive HER2 Negative Advanced Breast Cancer

7 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch HR Positive HER2 Negative Advanced Breast Cancer

RecordFirmDate
Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced Breast Cancer (NCT07285382)wanghaibo2025-06-25
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors (NCT06625775)TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)2024-10-29
Study of TYK-00540 Tablets in Patients With Advanced Solid Tumors (NCT06950086)TYK Medicines, Inc2024-01-02
A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy (NCT05890287)Tianjin Medical University Cancer Institute and Hospital2023-05-16
Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study (NCT06805812)Fondazione IRCCS Istituto Nazionale dei Tumori, Milano2023-05-01
Iribrine Plus Tucidinostat in the Treatment of HR+/HER2 Advanced Breast Cancer After CDK4/6 Inhibitor Failure (NCT05335473)Henan Cancer Hospital2022-05-13
A Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With Advanced Breast Cancer (NCT04796623)Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2021-02-04

Track HR Positive HER2 Negative Advanced Breast Cancer automatically

Every clearance here is in the API, with alerts when new ones post.